Jay M. Berman, MD (Moderator)
Professor of Obstetrics and Gynecology, Wayne State University School of Medicine; Director, Division of Gynecology; Chief of Gynecology Services, Harper-Hutzel Hospitals, Detroit, Michigan
Shannon K. Laughlin-Tommaso, MD, MPH
Assistant Professor and Consultant, Departments of Obstetrics and Gynecology and Surgery, Mayo Clinic, Rochester, Minnesota
Charles E. Miller, MD
Clinical Associate Professor, Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago; Director of Minimally Invasive Gynecologic Surgery and AAGL/SRS Fellowship Director in Minimally Invasive Gynecologic Surgery, Advocate Lutheran General Hospital, Park Ridge, Illinois
After completing this activity, the physician should be better able to:
||Describe the monoclonal nature of fibroids tumors.
||Identify the genetic mutations that are most commonly found in fibroid tumors.
||Describe ethnicity-associated differences in the presentation of fibroid tumors.
||Identify risk factors for fibroid growth.
||Describe the workup of a patient presenting with fibroids, including types of imaging.
||Explain the medical and surgical options available for the treatment of fibroids across the reproductive years.
||Describe the role of uterine artery embolization (UAE), magnetic resonance imaging (MRI)-guided focused ultrasound, and intra-abdominal ultrasound-guided radiofrequency ablation of fibroids.